OncLive On Air | Page 2

Snapshot of the 2018 ASH Annual Meeting in San Diego
We traveled to San Diego, California, for the 2018 ASH Annual Meeting, where we spoke with several experts across hematologic malignancies, including mantle cell lymphoma, chronic lymphocytic leukemia, and multiple myeloma. 
Buzzing With News From the San Antonio Breast Cancer Symposium
We headed to San Antonio, Texas, for the San Antonio Breast Cancer Symposium, where we spoke to several principal investigators who detailed new applications of novel therapies, surgical intervention strategies, and lifestyle modifications.
Exploring Strides Made in Ovarian Cancer & STS in Stanford
We headed to Stanford, California, for a State of the Science Summit on Ovarian Cancer and Soft Tissue Sarcoma, which focused on recent advances made in the treatment landscapes.
Reflecting on New Advances Made in NSCLC in Chicago
We headed to Chicago, Illinois, for a State of the Science Summit on Advanced Non–Small Cell Lung Cancer, which focused on recent updates in the field, particularly data from the 2018 World Conference on Lung Cancer.
Gaining Insight Into Genitourinary Cancers in Charlotte
We headed to Charlotte, North Carolina, for a State of the Science Summit on Genitourinary Cancers, which focused on the evolving paradigms of prostate cancer and renal cell carcinoma.
Keeping Up With Hematologic Advances in Clayton
We headed to Clayton, Missouri for a State of the Science Summit on Hematologic Malignancies, which focused on novel agents in chronic lymphocytic leukemia, advances in acute myeloid leukemia, progress in myeloproliferative neoplasms, and more.
Getting Educated With GI Cancer Therapies in Newport Beach
We headed to Newport Beach, California, for a State of the Science Summit on Gastrointestinal Cancers, which focused on the evolving paradigms of colorectal cancer, pancreatic cancer, neuroendocrine tumors, gastric cancer, and hepatocellular carcinoma.
Acquiring Lung Cancer Lessons in New Jersey
We visited Summit, New Jersey for a State of the Science Summit on non–small cell lung cancer (NSCLC). The meeting covered the current standard of care for early-stage lung cancer, approaches to locoregionally advanced NSCLC, updates in EGFR-positive NSCLC, and more.
On the Floor at the 2018 ESMO Congress
The 2018 ESMO Congress brought us all the way to Munich, Germany. At this annual congress, data across various tumor types were presented, including genitourinary malignancies, breast cancer, head and neck squamous cell carcinoma, melanoma, gastrointestinal malignancies, and lung cancer.
Clued in to Hematologic Cancer Treatment in Cleveland
We traveled to Cleveland, Ohio for a State of the Science Summit on Hematologic Malignancies. The meeting covered the evolving paradigm of chronic lymphocytic leukemia, updates in mantle cell lymphoma, treatment options for patients with newly diagnosed and relapsed/refractory multiple myeloma, unmet needs in myeloproliferative neoplasms, interesting genomic research in acute myeloid leukemia, and the challenges with treating patients with myelodysplastic syndrome.
Publication Bottom Border
Border Publication
x